Related Experiment Video
Updated: Jan 9, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
'Power under pressure' - defibrillation during hyperbaric oxygen therapy: a scoping review.
Sophia Nöhl1,2,3, Christian Burisch4,5, Daniel Gödde6,7
1Faculty of Health, Witten/Herdecke University, Witten, Germany.
Defibrillation during hyperbaric oxygen therapy (HBOT) is uncertain due to fire risks. Monoplace chambers strictly forbid it, while multiplace chambers require individual risk assessment, highlighting the need for clear safety guidelines.
Area of Science:
- Hyperbaric Medicine
- Emergency Cardiovascular Care
Background:
- Defibrillation is standard for cardiac arrest with shockable rhythms.
- Hyperbaric oxygen therapy (HBOT) involves an oxygen-rich atmosphere and increased pressure.
- Safety of defibrillation during HBOT is uncertain due to potential fire and explosion risks.
Conclusions:
- Defibrillation is contraindicated in monoplace hyperbaric chambers.
- In multiplace chambers, risks and benefits of defibrillation must be individually assessed.
- Further research is needed to refine safety protocols and establish guidelines for defibrillation during HBOT.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

